<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241838</url>
  </required_header>
  <id_info>
    <org_study_id>1717</org_study_id>
    <nct_id>NCT01241838</nct_id>
  </id_info>
  <brief_title>The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy</brief_title>
  <official_title>The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of heart rate on cardiac index in patients
      with or without left ventricular hypertrophy. The study will be conducted in postoperative
      heart surgery patients with a pacemaker.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient no of patients eligible for enrollment.
  </why_stopped>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac index</measure>
    <time_frame>At heart rates 65-80-95-110-125</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>At heart rates 65-80-95-110-125</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ejection fraction</measure>
    <time_frame>Heart rates of 65-80-95-110-120</time_frame>
    <description>Echocardiographic index of systolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strain</measure>
    <time_frame>Heart rates of 65-80-95-110-125</time_frame>
    <description>Echocardiographic index of systolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S-max</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of systolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E/E'</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of diastolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E/A ratio</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of diastolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E'/A' ratio</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of diastolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isovolumetric relaxation index</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of diastolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IVRT/IVRT'</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Echocardiographic index of diastolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End diastolic volume</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Volume of left ventricle and end diastole</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End systolic volume</measure>
    <time_frame>Heart rates of 65-80-95-110-125 beats per second</time_frame>
    <description>Volume of left ventricle at end systole</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Left Ventricular Hypertrophy</condition>
  <condition>Diastolic Dysfunction</condition>
  <condition>Heart Failure</condition>
  <condition>Heart Rate</condition>
  <arm_group>
    <arm_group_label>Normal left ventricular size</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Postoperative patient with normal left ventricular size</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Left ventricular hypertrophy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Postoperative patient with left ventricular hypertrophy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacemaker</intervention_name>
    <description>Routine postoperative temporary pacemaker Rate change of 65-80-95-110-125 beats/second in random order at day 3-4 after operation</description>
    <arm_group_label>Normal left ventricular size</arm_group_label>
    <arm_group_label>Left ventricular hypertrophy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled heart surgery including thoracotomy

          -  Ejection fraction &gt; 45%

          -  Duration of QRS complex &lt; 120 milliseconds

          -  Sinus rhythm

          -  Planned perioperative temporary pacemaker

        Group: Left ventricular hypertrophy:

        Thickness of interventricular septum and posterior wall &gt;11 mm.

        Group: No left ventricular hypertrophy:

        Thickness of interventricular septum and posterior wall &lt;11 mm.

        Exclusion Criteria:

          -  Active endocarditis

          -  Severe mitral insufficiency

          -  No patient consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Juhl-Olsen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology, Århus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology, Århus University Hospital</name>
      <address>
        <city>Århus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2010</study_first_posted>
  <last_update_submitted>August 3, 2012</last_update_submitted>
  <last_update_submitted_qc>August 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Left ventricular hypertrophy</keyword>
  <keyword>Diastolic dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Hypertrophy, Left Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

